Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.003 | 0.9 |